TABLE OF CONTENT: 1. Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. Key Insights 1. Prevalence of Key Diseases - by Key Countries – 2018 2. Pipeline Analysis 3. Key Industry Developments 4. Regulatory Scenario - by Key Regions 5. New Product Approvals 5. Global Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis, Insights and Forecast – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis, Insights and Forecast – By Region 1. North America 2. Europe 3. Asia Pacific 4. Latin America 5. Middle East & Africa 6. North America Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis – By Country 1. U.S. 2. Canada 7. Europe Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis – By Country/ sub-region 1. U.K. 2. Germany 3. France 4. Spain 5. Italy 6. Scandinavia 7. Rest of Europe 8. Asia pacific Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis – By Country/ sub-region 1. Japan 2. China 3. India 4. Australia 5. Southeast Asia 6. Rest of Asia Pacific 9. Latin America Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis – By Country/ sub-region 1. Brazil 2. Mexico 3. Rest of Latin America 10. Middle East & Africa Prescription Drugs Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Product Type 1. Generics 2. Orphan 3. Other Prescription Drugs 3. Market Analysis – By Therapy 1. Oncology 2. Anti-diabetics 3. Vaccines 4. Sensory Organs 5. Immunosuppressants 6. Anticoagulants 7. Others 4. Market Analysis – By Distribution Channel 1. Hospital Pharmacies 2. Retail Pharmacies & Drug Stores 3. Online Pharmacies 5. Market Analysis – By Country/ sub-region 1. GCC Countries 2. South Africa 3. Rest of Middle East & Africa 11. Competitive Analysis 1. Key Industry Developments 2. Global Market Share Analysis (2018) 3. Competition Dashboard 4. Comparative Analysis – Major Players 5. Company Profiles 1. Novartis AG 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 2. Pfizer, Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 3. F. Hoffmann-La Roche Ltd. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 4. Sanofi 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 5. Johnson & Johnson Services, Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 6. Merck & Co., Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 7. AbbVie, Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 8. GlaxoSmithKline plc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 9. AstraZeneca 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY) 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 11. Other Prominent Players 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 12. Strategic Recommendations

Novartis AG Pfizer, Inc. F. Hoffmann-La Roche Ltd Sanofi Johnson & Johnson Services, Inc Merck & Co., Inc. AbbVie, Inc. GlaxoSmithKline plc. AstraZeneca CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY) Others